dabigatran has been researched along with Chronic Liver Failure in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aigner, E; Balcar, L; Bartl, S; Datz, C; Gensluckner, S; Hametner-Schreil, S; Hofer, H; Lampichler, K; Lindorfer, A; Mandorfer, M; Pomej, K; Reiberger, T; Schäfer, B; Scheiner, B; Schöfl, R; Semmler, G; Trauner, M; Zoller, H | 1 |
| Chen, Y; Huang, K; Wu, M; Xia, H; Yu, S; Yu, W; Zhou, H | 1 |
| Adelmeijer, J; Bontemps, STH; de Kleine, RHJ; de Meijer, VE; Hulscher, JBF; Lisman, T; Porte, RJ; Reyntjens, KMEM; Scheenstra, R; Werner, MJM | 1 |
| Alamiri, K; Novak, JE; Yee, J | 2 |
| Caldwell, SH; Intagliata, NM; Maitland, H; Pellitier, S | 1 |
6 other study(ies) available for dabigatran and Chronic Liver Failure
| Article | Year |
|---|---|
Outcome of Budd-Chiari Syndrome Patients Treated With Direct Oral Anticoagulants: An Austrian Multicenter Study.
Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Austria; Budd-Chiari Syndrome; Carcinoma, Hepatocellular; Dabigatran; End Stage Liver Disease; Gastrointestinal Hemorrhage; Humans; Liver Neoplasms; Retrospective Studies; Severity of Illness Index; Vitamin K | 2023 |
Comparison of the efficacy and safety between rivaroxaban and dabigatran in the treatment of acute portal vein thrombosis in cirrhosis.
Topics: Administration, Oral; Anticoagulants; Dabigatran; End Stage Liver Disease; Hemorrhage; Humans; Liver Cirrhosis; Portal Vein; Retrospective Studies; Rivaroxaban; Severity of Illness Index; Treatment Outcome; Venous Thrombosis | 2023 |
In Vitro Evaluation of Pro- and Anticoagulant Drugs in Children with End-Stage Liver Disease Undergoing Liver Transplantation.
Topics: Anticoagulants; Blood Coagulation; Blood Coagulation Factors; Child; Child, Preschool; Dabigatran; End Stage Liver Disease; Female; Hemostatics; Heparin; Humans; Liver Transplantation; Male; Rivaroxaban | 2020 |
Dabigatran Reversal in a Patient With End-Stage Liver Disease and Acute Kidney Injury.
Topics: Acute Kidney Injury; Aged; Antibodies, Monoclonal, Humanized; Antidotes; Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; End Stage Liver Disease; Hemorrhage; Humans; Male; Patient Care Management; Risk Adjustment; Risk Assessment; Stroke; Treatment Outcome | 2018 |
In Reply to 'Idarucizumab Dosing in Kidney Failure'.
Topics: Acute Kidney Injury; Antibodies, Monoclonal, Humanized; Dabigatran; End Stage Liver Disease; Humans; Liver Diseases | 2018 |
Reversal of direct oral anticoagulants for liver transplantation in cirrhosis: A step forward.
Topics: Administration, Intravenous; Administration, Oral; Antibodies, Monoclonal, Humanized; Anticoagulants; Blood Loss, Surgical; Dabigatran; End Stage Liver Disease; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Preoperative Care; Severity of Illness Index; Treatment Outcome; Venous Thrombosis | 2017 |